product
live
viral
vaccin
anim
cell
egg
substrat
carri
risk
adventiti
viru
contamin
final
product
test
adventiti
virus
therefor
essenti
qualiti
control
step
manufactur
vaccin
biolog
medicin
nonspecif
screen
adventiti
virus
partli
base
anim
test
serv
well
decad
legal
ethic
imper
replac
test
cell
cultur
test
larg
solv
ethic
issu
cheaper
perform
recent
effort
compar
sensit
specif
anim
test
promis
nevertheless
cell
anim
test
limit
restrict
tropism
virus
may
detect
noncytopath
nonpathogen
nonhaemadsorb
virus
exampl
porcin
circoviru
pcv
dna
detect
two
rotaviru
vaccin
despit
routin
adventiti
viru
test
show
evid
contamin
pcrbase
test
offer
sensit
specif
detect
target
pathogen
howev
screen
potenti
virus
pcr
impract
nontarget
virus
would
remain
undetect
deep
sequenc
ds
also
refer
massiv
parallel
high
throughput
sequenc
offer
potenti
identif
extran
nucleic
acid
sampl
without
priori
knowledg
like
contamin
without
requir
propag
viru
method
alreadi
success
appli
detect
adventiti
agent
vaccin
cell
line
serum
bioreactor
multipl
laboratori
informat
method
viral
metagenom
develop
clinic
biolog
specimen
substanti
interest
among
vaccin
manufactur
contract
research
organis
regul
medicin
control
laboratori
evalu
method
routin
safeti
test
potenti
replac
exist
vitro
vivo
test
major
challeng
realis
potenti
identif
robust
sensit
specif
assay
design
wide
rang
method
exist
viral
metagenom
mani
earli
develop
multipl
option
exist
gener
sequenc
librari
sever
commerci
sequenc
platform
exist
base
fundament
differ
chemistri
develop
numer
bioinformat
pipelin
use
sequenc
classif
academ
commerci
develop
databas
read
search
constantli
evolv
given
paramet
import
suitabl
refer
materi
ensur
differ
method
gener
compar
result
addit
reagent
comparison
method
determin
run
perform
wellcharacteris
materi
defin
viru
concentr
requir
order
determin
limit
detect
particular
virus
viru
type
describ
candid
materi
qualit
comparison
method
run
perform
evalu
intern
collabor
studi
encompass
laboratori
studi
highlight
broad
rang
laboratori
informat
techniqu
use
consensu
exist
appropri
combin
method
achiev
maximum
sensit
discuss
major
challeng
incorpor
deep
sequenc
adventiti
agent
test
workflow
highlight
area
requir
particular
attent
describ
requir
futur
refer
materi
enabl
valid
comparison
method
primari
aim
studi
evalu
suitabl
reagent
refer
materi
deep
sequencingbas
adventiti
viru
detect
compar
result
obtain
independ
laboratori
use
varieti
sampl
prepar
sequenc
informat
method
identifi
optim
process
paramet
step
process
feasibl
given
larg
number
variabl
studi
aim
assess
sensit
particular
method
profici
individu
laboratori
outlin
project
present
world
health
organis
expert
committe
biolog
standardis
ecb
meet
committe
felt
project
could
provid
use
inform
valu
refer
materi
merit
current
use
method
particip
identifi
exist
network
contact
via
parenter
drug
associ
pda
food
drug
administr
fda
advanc
viru
detect
technolog
interest
group
particip
includ
vaccin
manufactur
contract
research
organis
academ
laboratori
regulatori
agenc
medicin
control
laboratori
interest
viru
detect
biolog
medicin
full
list
particip
laboratori
shown
collabor
group
exist
multiplex
quantit
polymeras
chain
reaction
qpcr
run
control
reagent
avail
studi
reagent
contain
virus
repres
rang
common
hazard
group
human
virus
unit
kingdom
advisori
committe
danger
pathogen
classif
varieti
genom
envelop
type
tabl
individu
virus
propag
cell
cultur
egg
passag
noncultiv
virus
isol
clinic
specimen
origin
viru
describ
tabl
realtim
pcr
rtpcr
cycl
threshold
ct
valu
determin
individu
viru
stock
virus
pool
predict
ct
valu
would
approxim
pool
viru
formul
mm
tri
ph
supplement
foetal
calf
serum
ml
reagent
fill
ml
screwcap
sarstedt
vial
frozen
sampl
pool
materi
assess
inhous
rtpcr
see
supplement
tabl
pcr
condit
determin
presenc
virus
tabl
virus
detect
follow
formul
henc
develop
reagent
qpcr
control
ceas
materi
deem
ideal
candid
current
studi
infect
pool
virus
confirm
intend
use
nucleicacid
base
detect
method
precis
concentr
individu
virus
known
howev
rtpcr
data
suggest
virus
present
rang
nucleic
acid
concentr
ct
valu
rang
detect
tabl
previou
studi
found
virus
detect
sequenc
modest
read
depth
read
presenc
addit
virus
reagent
consid
possibl
due
isol
sever
target
virus
human
clinic
specimen
propag
other
cell
cultur
addit
foetal
calf
serum
reagent
presenc
virus
known
advanc
two
vial
reagent
ship
laboratori
dri
ice
list
target
virus
known
laboratori
facilit
import
appropri
biocontain
laboratori
process
reagent
accord
prefer
method
technic
replic
request
mandatori
due
high
cost
involv
laboratori
ask
analys
entir
data
set
plu
random
subset
million
read
paramet
report
primari
analysi
total
number
target
virus
detect
b
rank
target
virus
c
correl
read
depth
number
target
virus
detect
major
laboratori
ran
two
technic
replic
replic
detect
target
virus
select
primari
analysi
event
replic
detect
equal
number
target
virus
replic
contain
fewer
total
sequenc
read
select
secondari
analysi
includ
report
nontarget
virus
detect
three
lab
b
rank
target
nontarget
virus
detect
three
lab
c
consist
viru
detect
replic
rank
determin
base
absolut
number
proport
read
match
indic
virus
account
fact
total
number
read
proport
read
identifi
viral
differ
greatli
laboratori
one
lab
report
difficulti
distinguish
noroviru
strain
due
larg
number
close
relat
sequenc
avail
public
databas
lab
provid
explan
report
hit
human
noroviru
rather
serotyp
gi
gii
result
plot
hit
human
noroviru
laboratori
consid
noroviru
gii
higher
overal
rank
hit
adc
merg
refer
sequenc
ident
similarli
hit
mastadenoviru
f
merg
reagent
avail
via
nibsc
catalogu
nibscorgproduct
refer
data
return
laboratori
one
laboratori
unabl
complet
analysi
within
studi
time
frame
wide
rang
sampl
prepar
informat
method
use
laboratori
two
laboratori
use
ident
method
tabl
supplement
tabl
four
laboratori
return
data
gener
use
two
differ
method
major
laboratori
employ
informat
methodolog
identifi
virus
blind
manner
rather
specif
target
known
virus
supplement
tabl
ten
laboratori
method
perform
technic
replic
vast
major
virus
detect
present
replic
fig
common
inconsist
presenc
noroviru
gi
gii
influenza
b
one
replic
absenc
supplement
tabl
nine
virus
discrep
observ
predominantli
bottom
rank
virus
posit
replic
ie
replic
viru
detect
supplement
tabl
fig
detail
breakdown
virus
detect
laboratori
shown
supplement
tabl
human
herpesviru
hhv
detect
method
fig
left
panel
parechoviru
rotaviru
detect
laboratori
fig
right
panel
noroviru
gi
influenza
b
detect
fewer
method
noroviru
gi
detect
fewer
laboratori
current
studi
aim
directli
compar
pcr
deep
sequenc
detect
virus
howev
except
virus
detect
fewest
laboratori
method
detect
realtim
pcr
ten
laboratori
report
detect
addit
virus
detect
three
laboratori
describ
tabl
least
addit
virus
report
singl
lab
report
presenc
corrobor
second
lab
target
parechoviru
highest
rank
base
proport
read
return
hit
median
rank
fig
noroviru
gi
lowest
rank
median
ie
detect
rank
vari
significantli
laboratori
notabl
rotaviru
vari
rank
median
may
suggest
differ
method
differenti
like
detect
given
viru
famili
virus
howev
low
sampl
number
wide
rang
method
use
preclud
statist
analysi
major
factor
influenc
viru
detect
rank
calcul
inclus
addit
virus
detect
three
laboratori
nontarget
bovin
viral
diarrhoea
viru
median
rank
sever
nontarget
virus
rank
higher
target
virus
fig
bottom
panel
current
studi
profici
test
recognis
multipl
experiment
design
consider
affect
abil
detect
particular
virus
result
obtain
current
studi
may
use
refer
use
materi
laboratori
detect
parechoviru
rotaviru
greater
laboratori
detect
astroviru
coxsackieviru
metapneumoviru
parainfluenzaviru
parainfluenzaviru
rhinoviru
sapoviru
greater
laboratori
detect
coronaviru
influenza
influenza
influenza
b
noroviru
gii
parainfluenza
viru
parainfluenzaviru
respiratori
syncyti
viru
nontarget
bovin
viral
diarrhoea
viru
fewer
laboratori
detect
noroviru
gi
well
nontarget
human
bocaviru
human
enteroviru
aichi
viru
bovin
parvoviru
porcineoth
circovirus
natur
materi
test
determin
product
product
stage
differ
materi
may
distinct
upstream
process
requir
eg
filtrat
concentr
centrifug
discrep
detect
target
virus
may
part
attribut
assay
design
exampl
assay
target
particleprotect
nucleic
acid
use
nucleas
may
discrimin
certain
signal
rel
target
total
nucleic
acid
though
notabl
one
laboratori
identifi
virus
report
use
nucleas
extract
method
may
also
affect
abil
detect
differ
virus
variabl
effici
revers
transcriptas
step
may
bia
detect
rna
virus
sequenc
librari
prepar
typic
requir
nanogram
microgram
amount
dna
may
challeng
obtain
certain
start
materi
lower
amount
dna
may
yield
adequ
sequenc
librari
case
deviat
significantli
recommend
input
may
problemat
good
laboratori
practic
glp
good
manufactur
practic
gmp
environ
amplif
pcr
system
employ
two
laboratori
howev
risk
bia
due
differ
templat
prefer
consid
molecular
techniqu
inclus
templat
control
essenti
avoid
identifi
fals
posit
due
trace
contamin
sampl
extract
column
molecular
biolog
reagent
sampletosampl
contamin
librari
prepar
sequenc
matrix
effect
may
broadli
defin
chang
sensit
specif
detect
assay
due
substanc
sampl
inhibit
extract
target
andor
copurifi
interfer
downstream
process
adventiti
viru
detect
like
perform
divers
sampl
includ
raw
materi
cultur
supernat
bulk
harvest
may
interfer
nucleic
acid
detect
method
competit
nonvir
nucleic
acid
eg
host
cell
neg
impact
limit
detect
concentr
may
vari
significantli
sampl
type
case
nucleas
treatment
may
increas
sensit
particleprotect
virus
use
caution
reason
describ
previou
section
detail
investig
matrix
effect
beyond
scope
studi
howev
futur
refer
materi
compat
varieti
matric
method
valid
use
matrix
similar
test
articl
import
bioinformat
algorithm
strike
appropri
balanc
speed
sensit
specif
size
sequenc
dataset
refer
databas
continu
grow
offer
obviou
advantag
term
sensit
howev
necessit
develop
new
sequenc
classif
algorithm
enabl
data
analysi
within
reason
time
cost
potenti
increas
fals
neg
rate
rang
method
use
current
studi
threshold
assign
hit
vari
laboratori
report
detect
viru
basi
singl
read
other
requir
addit
criteria
met
viral
identif
stringenc
determin
context
low
stringenc
maximis
chanc
detect
novel
virus
may
highli
diverg
databas
refer
risk
increas
fals
posit
may
appropri
eg
screen
master
cell
viru
bank
followup
test
perform
routin
test
scheme
defin
set
contamin
screen
higher
stringenc
may
appropri
minimis
fals
posit
eg
due
match
host
sequenc
similar
viral
gene
current
studi
focuss
detect
known
virus
mani
pipelin
employ
entir
compat
viru
discoveri
investig
simpli
alter
process
search
paramet
also
observ
variat
databas
use
sequenc
classif
publicli
avail
databas
host
ncbi
valuabl
incomplet
curat
consider
need
action
taken
sequenc
read
current
nonclassifi
later
identifi
viral
origin
size
breadth
complex
databas
pose
challeng
sequenc
identif
pipelin
especi
databas
contain
entri
whose
taxonomi
erron
assign
may
therefor
advis
adventiti
viru
screen
perform
use
curat
databas
even
though
breadth
coverag
may
limit
reagent
intend
use
control
assess
assay
perform
rel
result
present
herein
result
histor
run
reagent
profici
test
materi
sinc
assay
differ
design
paramet
reagent
enabl
user
perform
interassay
intralaboratori
interlaboratori
comparison
reagent
purpos
contain
singlestrand
dna
viru
class
viru
particular
interest
given
detect
two
vaccin
product
howev
circoviru
parvoviru
sequenc
detect
sampl
three
four
laboratori
respect
tabl
provid
evid
presenc
ssdna
virus
reagent
albeit
low
level
commonli
report
nontarget
viru
bovin
viral
diarrhoea
viru
like
origin
foetal
bovin
serum
use
reagent
bovin
parvoviru
detect
human
bocaviru
aichi
viru
like
reflect
use
faecal
sampl
sourc
sever
target
virus
tabl
human
enteroviru
categori
like
reflect
combin
authent
enterovirus
faecal
sampl
potenti
misclassif
read
origin
coxsackieviru
rhinoviru
short
sequenc
contig
obtain
circovirus
definit
identif
achiev
henc
origin
viral
read
determin
absolut
quantif
compon
term
infecti
unit
particl
genom
equival
avail
reagent
therefor
suitabl
determin
limit
detect
quantif
number
report
begun
address
limit
detect
particular
virus
deep
sequenc
potenti
replac
exist
vitro
vivo
test
empir
definit
limit
detect
possibl
virus
impract
limit
detect
set
virus
repres
major
genom
coat
type
minim
start
point
potenti
extens
includ
full
set
virus
screen
mandatori
futur
refer
materi
contain
purifi
viru
particl
repres
divers
size
genom
structur
gccontent
particl
structur
envelop
viru
kingdom
materi
subject
comprehens
characteris
includ
precis
quantif
compat
varieti
sampl
matric
commonli
encount
biolog
manufactur
restrict
particular
molecular
biolog
techniqu
sequenc
platform
sinc
like
chang
time
collabor
studi
highlight
divers
method
current
employ
adventiti
viru
screen
deep
sequenc
variabl
target
viru
detect
underscor
need
suitabl
refer
materi
enabl
assay
comparison
reagent
serv
use
first
gener
refer
materi
evalu
improv
method
monitor
intralaboratori
consist
enabl
interlaboratori
comparison
support
promis
nascent
applic
deep
sequenc
etm
pdm
ss
conceiv
studi
etm
pdm
ss
studi
particip
design
studi
etm
coordin
studi
data
collect
etm
mdp
analys
data
etm
draft
manuscript
author
revis
approv
manuscript
